These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1179114

  • 1. [Study of the M-H response, of the silent period and of post-tetanic potentiation in subjects with Parkinson's disease during treatment with L-dopa or Madopar].
    Ferro Milone F, Lorizio A, Nordera G.
    Riv Neurol; 1975; 45(2):236-46. PubMed ID: 1179114
    [No Abstract] [Full Text] [Related]

  • 2. Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
    Marion MH, Stocchi F, Quinn NP, Jenner P, Marsden CD.
    Adv Neurol; 1987; 45():493-6. PubMed ID: 3548262
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
    Poewe WH, Lees AJ, Stern GM.
    Eur Neurol; 1987; 27 Suppl 1():93-7. PubMed ID: 3322842
    [Abstract] [Full Text] [Related]

  • 4. [The association of L-DOPA and Ro 4-4602 in the treatment of Parkinson's disease (author's transl)].
    Campanella G, Pennetta R.
    Riv Patol Nerv Ment; 1974 Oct; 95(5):673-5. PubMed ID: 4470267
    [No Abstract] [Full Text] [Related]

  • 5. [Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination].
    Casacchia M, Barba C, Ruggieri S, Zamponi A, Agnoli A.
    Riv Neurol; 1974 Oct; 44(5):303-30. PubMed ID: 4217465
    [No Abstract] [Full Text] [Related]

  • 6. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    Rondot P.
    Rev Prat; 1974 Mar 11; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
    [No Abstract] [Full Text] [Related]

  • 7. [Disappearance of the disordered postural regulation of cerebral circulation by the addition of benserazide in parkinsonism treated with L-dopa].
    Boismare F, Samson M, Pouliquen A, Hacpille L.
    Therapie; 1976 Mar 11; 31(5):615-22. PubMed ID: 1013953
    [No Abstract] [Full Text] [Related]

  • 8. [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination].
    Campanella G, Pennetta R.
    Acta Neurol (Napoli); 1974 Mar 11; 29(3):252-63. PubMed ID: 4417098
    [No Abstract] [Full Text] [Related]

  • 9. Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience.
    Birkmayer W, Birkmayer GD.
    J Neural Transm Suppl; 1986 Mar 11; 22():219-25. PubMed ID: 3097256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Levodopa and decarboxylase inhibitors in Parkinson's disease].
    Gilland O.
    Lakartidningen; 1977 Jan 05; 74(1-2):37-40. PubMed ID: 318722
    [No Abstract] [Full Text] [Related]

  • 15. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM, Megna GF, Masi G, Specchio LM.
    Riv Patol Nerv Ment; 1974 Oct 05; 95(5):676-84. PubMed ID: 4470268
    [No Abstract] [Full Text] [Related]

  • 16. Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients.
    Ceballos-Baumann AO, von Kummer R, Eckert W, Weicker H.
    J Neurol; 1990 Feb 05; 237(1):24-8. PubMed ID: 2181074
    [Abstract] [Full Text] [Related]

  • 17. Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment.
    Jensen NO, Dupont E, Hansen E, Mikkelsen B, Mikkelsen BO.
    Eur Neurol; 1987 Feb 05; 27 Suppl 1():68-72. PubMed ID: 3428310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA, Gachoud JP.
    Praxis (Bern 1994); 1995 Oct 24; 84(43):1235-8. PubMed ID: 7481341
    [Abstract] [Full Text] [Related]

  • 20. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
    Mondal BK, Mondal KN.
    Pharmatherapeutica; 1986 Oct 24; 4(9):571-6. PubMed ID: 3094036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.